If You Invested $10,000 in Moderna in January, This Is How Much You’d Have Now

1 min read

Anyone who invested $10,000 in Moderna (NASDAQ: MRNA) at the beginning of 2020 and didn’t sell saw that investment climb to more than $59,000 as of today, a 490% gain. But that number hides an important lesson: Reviewing the information that existed, and when it was available, can help explain those profits, and how they might be achievable again in the future.

Image source: Getty Images

In December 2018, Moderna went public at a valuation of $7.5 billion in what was the largest biotech IPO in history. The company had only one program in phase 2 trials, and many of its drugs were vaccines, considered less desirable by investors because of low profit margins.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Baidu Confirms Plans to Join the Smoking Hot EV Market

Next Story

Why SM Energy Stock Is Soaring Today

Latest from Blog